Eurocor. Interventional Cardiology.

Eurocor Tech Headquarters Germany.
Dedicated to your heart.
Coronary stent technologies and special cardiovascular and endovascular devices made in Europe for the world.

IROS 2014 - Interventionell Radiologisches Olbert Symposium, Salzburg, Austria, January 16 - 18, 2014

  • Salzburg Congress
  • Visit us at our Exhibition Booth No. 2 (Biomedica)
  • Eurocor Live OP and Abstract Session
Eurocor Live OP
Op No.: LIVE 1601 / Live OP – Eurocor/OptiMed
Title: Stent post-dilatation with Freeway in the SFA
       Presenter: Prof. Dr. Manfred Cejna, Landeskrankenhaus Feldkirch
       Date: Friday, January 17th, 2014, 2pm – 2.45pm,
       Room: IROS – Europa Room

Eurocor Abstract Session
Abstract Session No.: FP 2102.1 Free Paper Session 1
Title: Drug-eluting balloon versus standard balloon for treatment of de novo lesions in the superficial femoral artery and PI-segment - Interim Results of the Eurocor Freeride Study
       Presenter: Prof. Dr. K-L. Schulte
       Date: Saturday, January 18th, 2014, 8.30am – 9.15am, IROS Paracelsus Room

Flyer Eurocor Scientific Contribution IROS 2014

The Leipzig Interventional Course (LINC), Leipzig, Germany, January 28 - 31, 2014

  • Trade Fair Leipzig
  • Eurocor is present at Exhibition Booth No. 15,Hall 4
Scientific Poster Session on Eurocor’s DCB
Title: Drug-coated balloons (DCB) for PTA treatment of de-novo lesions in the SFA and PI-segment – first interim analysis of the Freeride Study
       Presenter: Dr. S. Vonberg
       Date: January 28th, 2014, 2.40pm – 2.45pm
       Room: LINC studio, next to Main Arena 2

Title: Drug-coated balloon (DCB) for peripheral arteries: Postdilatation of nitinolstents with DCB or plain balloon in the SFA – Updated interim results of the Freeway Stent Study>y
       Presenter: Prof. J. Tacke
       Date: January 28th, 2014, 2.45pm – 2.50pm
       Room: LINC studio, next to Main Arena 2

Title: Drug-coated balloon in peripheral arteries: pre-clinical imaging, pharmacokinetic and physiologic study
       Presenter: Dr. R. Pogge von Strandmann
       Date: January 29th, 2014, 1.55pm – 2.00pm
       Room: LINC studio, next to Main Arena 2

Scientific Debating Session on Eurocor’s Freeway Stent Study Project
The last frontiers: Long SFA occlusions and calcified lesions
Chairmen: K.-L. Schulte, Ch. Metzger January 29th
The Freeway Study projects – status update

       Presenter: Prof. K.-L. Schulte
       Date: January 29th, 5.15pm – 5.22pm
       Room: Technical Forum, Room 3

Flyer Eurocor Scientific Contribution LINC 2014

SOLACI - Course for Interventionists in Training 2014, Buenos Aires, Argentina, April 23rd - 25th, 2014

Hilton Hotel Buenos Aires
Macacha Guemes 351
CABA, Argentina

Eurocor is present at Exhibition Booth No. 14A, Hall Pacífico
Scientific Session on Eurocor’s DCB

Title: Drug coated balloons vs standard balloons for the PTA treatment of de novo lesions in peripheral arteries (SFA and PI segment)- First interim results of the Freeride study
       Presenter: Dr. Alejandro Goldsmit
       Date: April 23rd, 2014, 10.30am
       Room: room Atlantico B, number 021

Title: Investigation of Inhibition of Restenosis by Drug-Coated Balloon (DCB) in Peripheral Arteries: Postdilatation of Nitinolstents with DCB versus plain balloon in the SFA and PI segment- Updated Interim results of the Freeway Stent Study
       Presenter: Dr. R. Pogge or Dr. B. Fernandez
       Date: April 24th, 2014, 2pm
       Room: poster number 165, Foyer

CICE 2014, Sao Paulo, Brazil, April 23rd - 26th, 2014

Sheraton Sao Paulo WTC Hotel
Avenida das Nações Unidas
12559 - Brooklin Novo
São Paulo - SP

Eurocor is present at Exhibition Booth No. 39
Exhibition halls: TC Theater, Ballroom 4/ Grand Ballroom Foyers and in the São Paulo Room

EuroPCR - The Leading Cardiovascular Course, Paris, France, May 20th - 23rd, 2014

Palais Des Congrès de Paris
2 Place Porte Maillot
75017 Paris

Eurocor is present at Exhibition Booth No. P18, Hall Paris, Level 1
  • We are looking forward to meeting you in Paris, France.
  • For further information please follow